We recently published 10 Stocks Shining Bright Amid Wall Street’s Dull Spell. Pony AI Inc. (NASDAQ:PONY) is one of the top performers on Tuesday. Pony AI bounced back on Tuesday from two consecutive ...

Discover why Warner Bros. Discovery urges shareholders to reject Paramount’s bid, citing higher value and certainty in the ...

Pony AI is scaling its Virtual Driver autonomous system across robotaxi, robotruck, and licensing segments. Read why PONY ...

Chinese robotaxi stocks surged in Hong Kong trading on Wednesday, tracking strong overnight gains in Tesla Inc (NASDAQ: TSLA) ...

Tesla surged after CEO Elon Musk confirmed that the company was testing its robotaxis without a human safety monitor. Musk ...

Overnight developments in U.S. markets lent some support. Robotaxi operators Pony AI Inc (HK: 2026) and WeRide Inc (HK: 0800) ...

Tesla's progress in robotaxis is highlighted by an analyst who recently lowered the price target on the stock. Here's their latest commentary.

Tesla, Inc. remains massively overvalued, trading at a $1.5T market cap and 15.5x TTM sales. Click here to read why TSLA ...

"Our benchmarking suggests robotaxis could reach 45% of the China mobility market share by 2035E. Our base case is Pony ...

Seeking Alpha's roundup of statements, announcements, and remarks that could impact the technology sector. Read more here.

Luminar shares are under heavy pressure Monday after the company announced that it initiated voluntary Chapter 11 proceedings.

Let's consider these excellent candidates: CRISPR Therapeutics (NASDAQ: CRSP) and Vertex Pharmaceuticals (NASDAQ: VRTX), two innovative drugmakers. Here's why they are both buys heading into 2026.